Foundations of Longevity Q&A
Dr. David Barzilai
MD, PhD, MBA, MS, DipABLM
Longevity has an evidence problem. The loudest claims are often the least tested, while the interventions supported by the strongest human data can sound almost ordinary.
We asked him what deserves attention now, what still belongs at the frontier, and why consistency matters more than perfect optimisation.
1. When you say “evidence-based longevity,” what does that change in practice?
It changes what I'm willing to recommend, and how confidently.
Wellness often focuses on how you feel now, which matters and shouldn't be dismissed. Evidence-based longevity adds a second question: what is likely to protect your health, function and independence over the decades ahead? Those questions have different answers more often than people expect.
In practice it means grading the strength of evidence before acting on it. I work with four tiers. At the top, established human evidence measuring outcomes that matter to a life, with broad clinical support behind it. Below that, persuasive but incomplete human evidence, where the biological rationale is strong and important questions remain open. Below that, early human signals, often small studies measuring laboratory markers rather than clinical events. At the bottom, preclinical evidence from cells and animals with no human data yet.
Every tier has a legitimate use. The bottom is where good ideas begin. The trouble starts when something from the lower tiers is presented with the confidence of the top, arriving as though the question were settled. Some of those findings hold up. Many quietly don't, and there is rarely a correction when they fail.
Two questions will get you remarkably far. What was actually measured, and in how many people? “Improved a marker in the blood” and “prevented heart attacks” are different claims, and the distance between them disappears in a headline.
Rank longevity interventions by evidence quality rather than novelty and the leaders remain familiar: physical activity and fitness, strength, sleep, nutrition, avoiding tobacco, and social connection. What's changed is how precisely we can identify where an individual stands and what they should do next.
None of this argues against the frontier. Emerging science is where the future comes from. It argues for order of operations. Foundation before frontier.
2. What does fitness research actually show, and what should a realistic week include?
In a cohort of more than 750,000 US veterans, the least fit group had roughly four times the adjusted mortality risk of the most fit.
That's the Kokkinos analysis published in JACC in 2022. The relationship was inverse and graded across age, sex and race, and it held after multivariable adjustment. Being unfit carried greater risk than any of the cardiac risk factors the researchers examined.
Want to keep reading?
The full interview with Dr David Barzilai is available exclusively inside the Seven Springs members app.
Continue exploring evidence-based longevity, practical health strategies and expert insights designed to help you make better decisions for your long-term health.
About the Author Dr. David Barzilai MD, PhD, MBA, MS, DipABLM
Dr. David Barzilai, is a longevity medicine physician and Lecturer at Harvard Medical School. He is founder and CEO of Barzilai Longevity Consulting, where he advises clinicians, health systems and organisations on translating longevity science into practice, and serves as inaugural faculty member and Trustee at the Geneva College of Longevity Science. A Diplomate of the American Board of Lifestyle Medicine, he served as medical editor of Pathways to Longevity, Harvard Medical School's first Special Report on Longevity.
